Results 231 to 240 of about 189,790,258 (290)

IGF2 knockout reduces but does not abolish osteosarcoma growth in vitro and in vivo

FEBS Open Bio, EarlyView.
To test whether endogenous IGF2 promotes osteosarcoma growth, IGF2 was knocked out in Saos2 cells via CRISPR‐Cas9. KO cells showed reduced proliferation in vitro, and knockout xenografts in mice reached only ~25% of wild‐type tumor volume. Insulin‐like growth factor 2 (IGF2) is implicated in osteosarcoma, but direct functional evidence of its role is ...
Shun Yao, Marco Archetti
wiley   +1 more source

Hearing Smarter: A Scoping Review of Artificial Intelligence Implementation in Hearing Devices. [PDF]

J Clin Med
Hanegan C, Andos A, Ranganath R, Ezeldin A, Price H, Ford J, Mangan A, Richter G.   +7 more
europepmc   +1 more source

First-line treatment patterns and real-world survival outcomes in PD-L1-negative locally recurrent inoperable or metastatic triple-negative breast cancer in the United States. [PDF]

Breast Cancer Res Treat
Traina TA, Serra E, Bedard J, Levesque-Leroux M, Gagnon-Sanschagrin P, Guérin A, Guenther S, Joseph G, Guan V, Salcedo J.   +9 more
europepmc   +1 more source

Cardiac Resynchronization as an Enabler of ARNI Efficacy: Insights From a Real-World Cohort. [PDF]

J Arrhythm
Santoro A, Spaccaterra L, Collantoni M, Baiocchi C, Natali BM, Lunghetti S, Pagliaro A, Manetti N, Morrone F, Fineschi M, Palazzuoli A.   +10 more
europepmc   +1 more source

Clinical Pharmacology in Transgender Medicine: What Gaps Remain? [PDF]

Clin Pharmacol Ther
Cirrincione LR.
europepmc   +1 more source

The end of the world or the end of Capitalism?

, 2016
openaire   +1 more source